Fluorescent in situ hybridization studies in multiple myeloma

Hematology

Volumn 14, Issue 2, 2009, Pages 90-94

  Yuregir, Ozge Ozalp ^a   Sahin, Feride Iffet ^a   Yilmaz, Zerrin ^a   Kizilkilic, Ebru ^a   Karakus, Sema ^a   Ozdogu, Hakan ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

FISH; Molecular cytogenetics; Multiple myeloma

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 13Q; CHROMOSOME 14Q; CHROMOSOME 17P; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE 45,X; KARYOTYPE 46,XY; MALE; METAPHASE CHROMOSOME; MULTIPLE MYELOMA; NUMERICAL CHROMOSOME ABERRATION; PRIORITY JOURNAL;

ADULT; AGED; BONE MARROW CELLS; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 17; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; MULTIPLE MYELOMA;

EID: 66949157672     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453309X385250     Document Type: Article

References (14)

1. URL: http://AtlasGeneticsOncology.org/Anomalies/MMULID2038.html
2. Zandcki M. Multiple myeloma: Almost all patients are cytogenetically abnormal. Br J Haematol 1996; 94(2): 217-227.
3. Pantou D, Rizou H, Tsarouha H. Cytogenetic manifestations of multiple myeloma heterogeneity. Genes Chromosomes Cancer 2005; 42(1): 44-57.
4. Yilmaz Z, Sahin FI, Kizilkilic E. Conventional and molecular cytogenetic findings of myelodysplastic syndrome patients. Clin Exp Med 2005; 5(2): 55-59.
5. Sahin FI, Kizilkilic E, Bulakbasi T. Cytogenetic findings and clinical outcomes of adult acute myeloid leukaemia patients. Clin Exp Med 2007; 7(3): 102-107
6. Huang SY, Yao M, Tang JL. Clinical significance of cytogenetics and interphase fluorescence in situ hybridization analysis in newly diagnosed multiple myeloma in Taiwan. Ann Oncol 2005; 16(9): 1530-1538.
7. Smith A, Wisloff F, Samson D. Guidelines on the diagnosis and management of multiple myeloma 2005. Br J Haematol 2006; 132(4): 410-451.
8. Hallek M, Bergsagel PL, Anderson KC. Multiple myeloma: Increasing evidence for a multistep transformation process. Blood 1998; 91(1): 3-21.
9. Seidl S, Kaufmann H, Drach J. New insights into the pathophysiology of multiple myeloma. Lancet Oncol 2003; 4(9): 557-564.
10. Schmidt-Wolf IG, Glasmacher A, Hahn-Ast C. Chromosomal aberrations in 130 patients with multiple myeloma studied by interphase FISH: diagnostic and prognostic relevance. Cancer Genet Cytogenet 2006; 167(1): 20-25.
11. Magrangeas F, Cormier ML, Descamps G. Light-chain only multiple myeloma is due to the absence of functional (productive) rearrangement of the IgH gene at the DNA level. Blood 2004; 103(10): 3869-3875.
12. Terpos E, Eleutherakis-Papaiakovou V, Dimopoulos MA. Clinical implications of chromosomal abnormalities in multiple myeloma. Leuk Lymphoma 2006; 47(5): 803-814.
13. Elnenaei MO, Hamoudi RA, Swansbury J. Delineation of the minimal region of loss at 13q14 in multiple myeloma. Genes Chromosomes Cancer 2003; 36(1): 99-106.
14. Zojer N, Königsberg R, Ackermann J. Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization. Blood 2000; 95(6): 1925-1930.